Multitarget Pharmacology of Sulfur-Nitrogen Heterocycles: Anticancer and Antioxidant Perspectives

Area of Science:

• Biochemistry
• Oncology
• Medicinal Chemistry

Background:

• Oxidative stress, driven by reactive oxygen species (ROS), is intricately linked to cancer development and progression.
• While ROS can cause DNA damage and disrupt antioxidant defenses, cancer cells often leverage oxidative environments to promote survival and proliferation.
• Existing antioxidant therapies have yielded variable outcomes, highlighting the need for more effective strategies.

Purpose of the Study:

• To explore the dual role of oxidative stress in cancer and the potential of novel therapeutic agents.
• To investigate sulfur-nitrogen heterocyclic derivatives as multifunctional compounds with both antioxidant and anticancer activities.
• To understand how structural modifications, such as phenyl group substitutions, influence these dual properties.

Main Methods:

• Literature review on the interplay between oxidative stress, cancer, and antioxidant mechanisms.
• Analysis of recent research on sulfur-nitrogen heterocyclic compounds in oncology.
• Examination of structure-activity relationships, focusing on hydroxy and electron-withdrawing substituents on phenyl rings.

Main Results:

• Reactive oxygen species (ROS) play a dual role in cancer, contributing to oncogenesis and enabling tumor survival.
• Sulfur-nitrogen heterocyclic derivatives are being investigated for combined antioxidant and anticancer effects.
• Hydroxy substitutions on phenyl rings enhance antioxidant activity, while electron-withdrawing groups, particularly at the para-position, boost anticancer potential.

Conclusions:

• Targeting the complex relationship between oxidative stress and cancer requires innovative therapeutic approaches.
• Multifunctional drugs, like certain sulfur-nitrogen heterocycles, offer a promising avenue for improved cancer treatment with potentially fewer side effects.
• Strategic molecular design, incorporating specific substituents, is crucial for optimizing dual antioxidant and anticancer efficacy in novel drug candidates.